Micky Tripathi, the AI czar for health care, discusses the challenges of integrating artificial intelligence into government agencies and the industry. Mohana Ravindranath joins to delve into biotech breakthroughs, including Amgen's promising obesity drug. Meanwhile, a successful serial CEO shares insights into leading a well-funded obesity company amid evolving treatment landscapes. The conversation reveals the intersection of technology and health, highlighting the exciting future of clinical trials and the obesity treatment market.

Dr. Micky Tripathi discusses how AI can enhance patient care and the risks it poses, HHS's approach to implementing AI, the role of ONC in advancing health IT, the establishment of an AI task force at HHS, and how AI can empower patients to take control of their health journey.